Centessa Pharmaceuticals plc (CNTA) Tops Q2 EPS by 22c

Centessa Pharmaceuticals plc (NASDAQ: CNTA) reported Q2 EPS of ($0.26), $0.22 better than the analyst estimate of ($0.48).

For earnings history and earnings-related data on Centessa Pharmaceuticals plc (CNTA) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• AeroVironment restates quarterly financials, citing $89M goodwill error
• Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins